Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
Journal article published in 2018 by
David Wyles,
Fred Poordad,
Stanley Wang,
Laurent Alric 
,
Franco Felizarta,
Paul Y. Kwo,
Benedict Maliakkal,
Kosh Agarwal ,
Tarek Hassanein,
Frank Weilert,
Samuel S. Lee,
Jens Kort,
Sandra S. Lovell,
Ran Liu,
Chih‐Wei Lin
and other authors.
,
Franco Felizarta,
Paul Y. Kwo,
Benedict Maliakkal,
Kosh Agarwal ,
Tarek Hassanein,
Frank Weilert,
Samuel S. Lee,
Jens Kort,
Sandra S. Lovell,
Ran Liu,
Chih‐Wei Lin
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 